Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxObnNXQXlaUjlNVUtBTGYtZ2gxcHJjdnBfV2hKLUYxSG5YQUhrTWJhd1hxMkJ6cE5scGpreXBRTGZWNjNmSU1EZXgtMHR1TDJRTXB4S1hZZ09COEZtLURtVFlFSDVwaUxWSW1MMm9lT0t0UmRCMFdsd0NXUXhQeHExNk1SNHB1MHBKQURYc0JJTXJLUEx5VDFhcDY5aFNfSTB2ZkgycEtB?oc=5" target="_blank">Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma</a>&nbsp;&nbsp;<font color="#6f6f6f">CancerNetwork</font>
MLB playoffs 2026: Inside White Sox's postseason pitching plan
Michael Douglas Tells Bill Maher About Smuggling Marijuana in Suitcases, Slams ‘Nepo Baby’ Label
Ben Simmons to make his Kings debut against Golden State
Trump Announces White House Inquiry Into Fed Governor Lisa Cook
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxPZ0lwMlgyb0prZndsRVk5S3dqUGstdjdEaVYtbHhiWFRaS0IwQXlpbjNNd3p4ZkdjR0FibnRqeXZZQWtINS1ubUVZeVl2dTl0aW9zWFJyd2Vka2hia3U3aGJiV3BVblNSWHVuWjVNTGdyM3NGSzl0RVBOSm83V0lfdkdQNml1blZjSUVSTUlWQ04?oc=5" target="_blank">Trispecifics: A New Strategy to Prevent Antigen Escape</a>&nbsp;&nbsp;<font color="#6f6f6f">Targeted Oncology</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNbmtiVHZocGdMWGo0TXZVUEEwNFNpQWw0NzdiWXpvLVpmbzJ2SHNMU0gwQkNTZ05KdDZKekZGdkRic2NYU1RYQTN6MUUtTFVWQ3B6ZEpOT2VqeFFBOElUZHltdTlkSkY5UC1OMGNCcER5MDJjWlFDTEg5dEtYVGx1djdhelJVUlVvZVlHdG01Z2FnUQ?oc=5" target="_blank">Immune cell engagers in lung cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPMFRwU0gtdVlYOHRyeFdRWU4zMmxiWC1ueGNaWTNFemRjUmtXUFpWcVV1ZUQ3LXlWc0JjeWVET3lsRk9aaWM2Z3VEV1FHd1d0czh2dG1oa3VNOWFzV2N1c2k1czFnX24wRnUyTTBxLUdITHdwUndDNGxtazJ0azFDS21tNmJzVXFZbWcwWFVIZGJBSk85SVFyRll6TjQyRnlfeTJqZGpsaVpScTVDRlJKd3d4Um41NlV5NFlj?oc=5" target="_blank">New T-cell engager therapy shows effectiveness in advanced solid tumors</a>&nbsp;&nbsp;<font color="#6f6f6f">News-Medical</font>
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQYWtsck1Nc0tkUnNkaHpPU1VBMzE5Ym1LM3g1eUtuTU42dTUwTjU4dFZyY3RmTXQ3WmVGSEVhdjFaUzRSLVRIMklSWHJiRGN6U1FvcDE0U2ZpT0NEMG5WVEVnck1YLXJ4VEVPd3lmSmZSRHFjdUN5c0xyaWRQZTdnZTg2M0JEQnRObnZSblowcnBzOW1xWFd1WVYwU1UzWnBF?oc=5" target="_blank">Engineering the next generation of T-cell engagers</a>&nbsp;&nbsp;<font color="#6f6f6f">Drug Target Review</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOUmt4TjI4cGt1MFVDd0hCWmxHOUZfaDJnRkVWMWFTOGFfZGpsRDhqZ1pVOFlKOFMtSjYzb1dFLXljdnc2OTdiVG5rR0paV3E2OGczLU1rYXFFcmN4cVNrRVJkcEFLNXAxdWxlaVc4YWQycXdPc0xkSXMxeW1od2lUOTdyOTQ0dWdlT1VkZ2ktSlk4Zw?oc=5" target="_blank">Cytospire hauls in $83M for a new type of T cell engager</a>&nbsp;&nbsp;<font color="#6f6f6f">BioPharma Dive</font>
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQSjZnX3cxTjM3bFdnNHp6RU5zRkRab09XM010UGV0eDRJcTUzbGs1MmtrdV9IX2lsN19ZOXF4Qmp4VDhZVGx6RGFrMXV6V1k2aXlGaUk0ZjJtTTVWNFVlZnhpY1ExMjR1bVV4YXhnRU9hWnBRWWlvWkVfNU9jbkdHaTQxSTFZNEpVT0ZmanFBYU1hM0hCRGJnWl9kOWQyb0NFbGd5eGgtU0g?oc=5" target="_blank">T cell engagers emerge as a compelling therapeutic modality</a>&nbsp;&nbsp;<font color="#6f6f6f">Rockefeller University Press</font>
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxPQXA5TVg1cFRDRXMwdzIyUFZYWUEwRFpNUlRuUUF1Yy1zNklyQXNyNlB1cHU1UEFGS3pIZHNtaDdvaHFoYWduX2ZDdXNwTFdITzdrMWFBYWFRUHNmZ3BXVllCWFAzY0JUQjBZWlRrTDdLbnUwSGlNeGhTdHF2YUFRMldGWHFNSGNh?oc=5" target="_blank">UK's Cytospire draws in $83m for new T-cell engager platform</a>&nbsp;&nbsp;<font color="#6f6f6f">pharmaphorum</font>
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxOUkI3ejBuRXJLQ3JENXdLdHFYSVMwMjRhMWh2RDBuVUJQem5xRDlwMjZqbHBoQkRmajViTG8yZDhCbHFBQ0NaRVJ4XzN1VlU2T0FIcHptRmZ3TFM0Qm5JNEpSaU9ZUjJvMFV6WHdDUmFHNlVuUnZMYUxzNWxFYkpTMzM0WG54aXpDdkRLVTg0UGlJenVuT1J4QlFLbmg?oc=5" target="_blank">Next-Generation Precision Medicine Platforms Come for Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">The Scientist</font>
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQYU5NYkdFaUJ6QnlfOEE4elI1R1dyNW1FMzRYb2J5YktJUkRhaEZvX1cwcnBqaUhURVlPVlpTZ19OZ2VuTnBaMGtsTFhtWHQxbGJKYWppLW5hbElIeTFZVmFzalRhc1JmS05EVTlCX2JxMVJsc3lDdGExUXF4dFdNUE5sWWpRRTJPN01Cc2paZ3U5MlVvNm9Zd3FyRF9OSmtnNEE?oc=5" target="_blank">What New Treatments Are Improving Survival in Small Cell Lung Cancer?</a>&nbsp;&nbsp;<font color="#6f6f6f">Cure Today</font>
<a href="https://news.google.com/rss/articles/CBMiuAJBVV95cUxQcG1LSHREWWRGQU9lZGxMTWF6dkMwNkNTcGthYUVpREI1dWIxU0wyUk9pU3hhX0wwOWxfcnVkVERNWnE4Sm9jVVVpNnNPTHF5VWx4TUp0VzVMVzI5clBJVGYydnNzVW9vcExyNkVhdlZjM0NfYzZveWU5TnlOUm5MVUQtY2NLdHpfb0dPb1hmUXNZZlJfQ01IVDBSdzR3Ql9zVEQ0MkY5eXg0bThaWUFsYWRnYWJQclh6WndaRTdUX2s0Z2J1VVFOZ2ZqbmxYM29CbzlzbWlpTnBoV05aaTZxTHpmRlVKRjB3NGZMV3hqWGctZm9aZ3A3WE44YzBIX0o1dkM0YUVzd0p0YjhoMEJIUzFWV3ZzZjJjVWVPaG1ScmxSaVd3S3ZvdmdaY3pQSHM3VWlDLVlRYkM?oc=5" target="_blank">Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases</a>&nbsp;&nbsp;<font color="#6f6f6f">GlobeNewswire</font>
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxOMGgxRUlQSWVZR2pENG5COXJ0Z3dQamdDUXNkQlY4WXREckN2anZvQnNMNFN3LTJGdFNtb0lRUGVLOHJfdmxEaDJXOFA2Vk1RX3M0YTZ5bGNNLVZIZGFYOHF0VTlzelhPcjMyNlJGQW5Yc1N6a2hYMTF0TnJfYkpTcy0tdUxyakdheUZrRmRxX3R2UktGWWpnbl9IMThHcm5BcG4zRV9hR0EyRWJUZUE?oc=5" target="_blank">Emerging Strategies in Prostate Cancer: Molecular Glues and T-Cell Engagers</a>&nbsp;&nbsp;<font color="#6f6f6f">CancerNetwork</font>
<a href="https://news.google.com/rss/articles/CBMijwJBVV95cUxPSG1pdXRUWmJxSTNqMW8zS2hOM3pOMXpDR2xqVkRtZ0ljeEpfekNfbTlwYURkVjgtNnhFeVBpYmZGWnlrTml1RG5mQW5oWWFrbEpSeGJNUGhQSEx6V0g4RFR5ckxlWlQ0WWlSQkd1T1hjMGFaNlRMU2V1OElESDk2Vnl2bk1zTldhTU1nZW0zRFlCR0xMQ1UyOVZ2RWtnM2xCMmVCTlhvcEVneUF6azdjRWkyQmdkTl81cXYyaXRScDlOSElLNmpQWjQxQ0hmb2NTMm0zVDBfMjlJb1R5dlJWbThlaG81SWxpbXc0N0U4dUdDbUJIRXlZRGJMV2xQaFd5YU9iRjRHUG5rOGE1UG9z?oc=5" target="_blank">NextPoint Therapeutics Announces Clinical Entry of NPX372, a First-in-Class B7-H7–Targeted T Cell Engager to Treat Solid Tumors</a>&nbsp;&nbsp;<font color="#6f6f6f">Business Wire</font>
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNQ2hDWnkybkVwbVFDbUhQMzU3YW9WSmpCdkMwN3VPeDNVOHQwTVZDVm1OcTBBN3JYdXBLeE93RFgyenJPa1JFM1pONlgzV2RpeTNnOFYwS25wbGRyWVp5VEh5Uk04RUphUWtYVmJ1OVBZUEh5Wm9HaFZoakstUlZHNlphSzh2SW9URjdMSEMzWUpyLURvZFlfWFltTzczcVRRODJ6TlctakFkeE0?oc=5" target="_blank">Gilead's $2.2B Ouro buyout delivers autoimmune T-cell engager, new purpose for Galapagos</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Biotech</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQdU5ROTdrX25ybWhCSEJEd05DeVR5X2d1dDhndVVaZzVDdmRPbzBmQ0lJZVIybTdwSVZqU2xlajFiTDhFTXJqaHNyTnVRWlh5bllvUnotNVROVnZESjluUEJhVjhVOXMxRE1PMHJZN0JwQkswSlppX2Q4dEpISjRjRWtiTkJ6QWxSN0wtbkF5TjllUQ?oc=5" target="_blank">Smart control of CAR-T cells: emerging strategies for safer and more effective cancer immunotherapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxOYkRNZE11NGFRcVFUVWRWcGx6WjFYVHpwRkZiQWFyNTVrcExZMWR3OVEtTFdBUUxpZHEycVFCMThUbndvN2Y3RTNRZEdONHhFMmZ4ZjFNdlY0bUJyVEVGdk9feV9pM2dGWG9jeDhYVUZjOW1xNHQyelkxazNfQ2FQSVdUOHZOT2MtanJicG50WGJQQ09VSVVjYkZLLWk?oc=5" target="_blank">AbCellera, Vertex partner on next-gen T-cell engagers</a>&nbsp;&nbsp;<font color="#6f6f6f">BioPharma Dive</font>
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQcXk2MTRFdnVwRUxBSkxrTkpaX2VhSUgzRFRlV3YyZkgxS2VrUkJGWXdTOFVGYkdISFhqNW9oZFBtSlV4WEJ2TE5NNGpBRTFUdW1Od21IY0J6cEpSbVZ0Wnl6VVQ5dmVtYllQbU5KTzFBbUZ2eC1yOGZBNko4SkFteGpFWmhzUzV0ZURIZTZhU1I?oc=5" target="_blank">Future Directions and Emerging Therapeutic Innovations</a>&nbsp;&nbsp;<font color="#6f6f6f">Targeted Oncology</font>
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQWXVGRXNpN0x4dEZSSkJUeUZ5cEhBSEsyRHdUTktlWGpSUFNRQVE4V25tckprbEVaR2xmM2drWDBIbDN0SFpxZjZKTWRYWThDdE5hWHlfbmxkNEpEeHlJbzNNZjVfXzZtTmJXRFVkR2gzNDQyX3R2UUpIR1VocUh2bDlLZ2xjWlhUSGdDcWY0MHNyV2JpMURTOEh4ck1TZw?oc=5" target="_blank">How New Therapies Are Changing the Game for Small Cell Lung Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Cure Today</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNbUpxNTFqRDRfZ1ZSWkxaNElFaDE4T2FvTVRZNDcxX0tXc2xoZW11LXpZVU1nbWx6QXUybUVXTDVWZ21ubkkyUjVxSy1zWEdpWG1sR2FRTTZwT1hDb0xhWHhSdy1faGZWRFV4UWp4U2RMNldKWU5ORDNRSExfeTZZTVJGaTF6NXVNWHIwR0o5aDFiQQ?oc=5" target="_blank">CAR-T and BiTE: new horizons in the treatment of rheumatic autoimmune diseases</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQWC16LUxrcEE4TlFDNi1jek8wOFBwSUYzb3NwNThiTHBBYlpGNVVuRWNGZkJaUWVqNmI4d3JLOUw1RjNRYWk3clBfQjJjWm9Ya0w0NjRySXREMU11bjRQVVNGcDVrU2hvTTNrT0hxdmc2cGdWNE5TcUhQVFBxNXBWLW9TU3lTbTRmTHdfUzc0RXI?oc=5" target="_blank">Crossbow raises $77M for new cancer immunotherapies</a>&nbsp;&nbsp;<font color="#6f6f6f">BioPharma Dive</font>
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQNy15ZUhxdUg2WTVoOUNHcWhRMTNkV2RIZjlTSzZuYTR5aTJEa3hIT0dWXy12M0RmZWkxdHJpUng4M2JmdFpfR3dHNDV4NjdfME55aThsdlVPMm5VSm01NWdBajE1R2NyLW54SUVaVWw0WjZjSzYzR2FUVnlzY0NqYUkyd20tdmdKb0J3bFRTX0poUXhUbXZNVi1vQnp4bEJ4?oc=5" target="_blank">GSK pens $50M LTZ pact to join Big Pharma peers in emerging myeloid cell engager space</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Biotech</font>
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOV2JhUGlDeEJrc3pjWTI4ajQtaFhwRllFZl9Oa1otQ2xqdFNHbU81YV9xenpQS3lFQ2M1UUxJNjVHOW5CVGN6dlBXU0dORWFMeTl6WFNkS1cyNDVhR2h3Y0V6S1dLekhIdjEzUjZ0ZnFIcERJYkpxZUszUWY4Zy13a3Q5d3c0ekVfV0VjTzZXWTYybkdSODdV?oc=5" target="_blank">Navigating New Horizons in Neuroendocrine Prostate Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">CancerNetwork</font>
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPMUZvV1NOX3lrTjRNV2UxT3drQWRkTFZDNzhnOXd2a1FQYjVrLTBkaFlROGlZbVZXcXVwYXNWQjZiYThqYnZFVkFuTDdVOENxRWxQd2p2N010X0dpU1RpS0IwSzFlVGZzQlZHTWJlZEtRR0FPTWFNeEE0aGw4R0kxTkl1Ym1tQndUYkxj?oc=5" target="_blank">The Shift to Complex Modalities for Cancer Treatment</a>&nbsp;&nbsp;<font color="#6f6f6f">PharmTech.com</font>
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOeTFEMDA5MW9HdExLbWN4RU5HbmN0eXBMcER1ZlVJbVVQbS1IcWluV1hoNm5HXzQ0N29NdUxCOUUtV2ZoMEpfMnM2QVJmMjVWLVd5QV9ycEQycm4wMS1yYlFVd2s1VkpNLVZKRzRZM3dOZXBWNF9GVnhGaVVHdzJDQUU2bWV6TGtGcjRYY0xHSktwTzhfMEFj?oc=5" target="_blank">UCB inks $2B Candid buyout to join Gilead in autoimmune field</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Biotech</font>
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQRERHa1BOeGNUVjVOcXlPMVhJdG90V1ZWSjlwLWVFRkpiUU1jX3dON3hYbVNqZ3VoaG9vaXdLeVNINUxNUnR4aC1nSkVreE1RSzVzZlVMdFRzU1VGUDlVYy03RzZiVS1ibGdRS2xnVUZoT0VTVDhzQlgxb001SnBvWHNXeHlhQjNTVkdvTUxJbWdjVXIwcjNjandXX1NXRnNFa1VPeUhTdzA?oc=5" target="_blank">UCB enters TCE space with $1.1B deal for autoimmune candidate</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Biotech</font>
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQRlkxX296RjhMQ1lyQ0U5RmVtdTFfbEx6djBxZWFfUTlrM1JSaHV1clJQRXI2ekRyckhQMERiVjN4WXhXOFhhUUZBX1ZObFZDNzhHMXdrZ1ZqclgxamZUc3lqYV9sNVJjZERxdVFBMnBpTG9IeG1naDJzNXFoRU15Sko2ZHo3UWhiY1RVNnR5M3ROT0RZTm5PeVBNTC1OS2w0WndKUjNWdW1pMjdNVHNz?oc=5" target="_blank">Oblenio Bio Raises $62M to Advance New Therapies for Autoimmune Diseases</a>&nbsp;&nbsp;<font color="#6f6f6f">citybiz</font>
<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxOeGdmbENQWExRZmpjemtpZGh4WFFyWUc3R0RFS19JY3dQYzFEUzBSa0lmRFI4Q3Q4VThnS3Y2U3A5bjVxaFp6Y256MEJKanJJVTY5WDFwempYU0ZwOTZCWVlJemlRMFRnUWpHdlJPLUlTNXVnSXBUUVlLd25VWWdmZmRBWU1ydklQQmtFV01OTzd0UG55TlRJY1lwenREbUYwdG1PQXJ2eGpPa2Zhc2x5dWV5WllMLWVpZjNYWEtMRmlleHQtY2JVdjBIRU53X01TeE5v?oc=5" target="_blank">Advances With Checkpoint Inhibitors, T-Cell Engagers, and ADCs Converge to Reshape the SCLC Treatment Paradigm</a>&nbsp;&nbsp;<font color="#6f6f6f">OncLive</font>
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQSEl5RUtOX3lDTVdRa1lPOGdKYzUtZlByZ29WZkdTYnBDSEZZczJHaXM0WnJPRnQ4VHF0endhNFRjVG81M1FJQzB6a0VPa3lGX3JwZ3hhcmVSN2dQVm45akZmV1hZN0JTR21NR054Mjg3djc4X25jbjhaNWl4NTVwOUg4M0JLdTNUbE9RckdaMUhyZno5d2NfMWJGWElXQmJkY3c?oc=5" target="_blank">J&J makes $1B upfront bet on emerging DAC space by netting Firefly Bio</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Biotech</font>
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxNLXBISE5GSFVSU0J3LXdlTUpVcmZsb1gtcU1MRFlCSW81UUVRNUMtaWVqVV9ESTJuYXJGYXg4SjZDY0Fsa01waU53bUZkYUJsZUJ5eVFZc3I3bVRQejBJQXIxaVRZWFMyVmx2ZHRyZy1HQnJqa1dVeW1HSzFkV3NzN2ZkeXkyWGZ6WnJtUElyWnRQUm1tS1Zpb1Ryc3dnRnN1NGJNRmdINU1WTnJpcjRQUkk0U1FWMFRYcmR2bkhIMnVnUQ?oc=5" target="_blank">Scientists explore new frontier in autoimmune disease treatment by resetting 'rogue' cells</a>&nbsp;&nbsp;<font color="#6f6f6f">PBS</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE55VVBjV2dfT1ZUbjBaTXpBQjFXZWhnRlJjNzdCR2hLR2owMGJ3cHZHVkdfMGQ1OWhlcXN4SE5FZ2J2SzQ1eXZXVUxnazkyaUIzX3ZZbmpVWXpaNEQzLURR?oc=5" target="_blank">New immune cell engagers for cancer immunotherapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>